Zobrazeno 1 - 10
of 58
pro vyhledávání: '"V. V. Mashin"'
Autor:
V. V. Mashin, A. N. Sergeev, N. N. Martynova, T. V. Antipina, E. I. Sakanyan, V. V. Kataeva, N. V. Zagidullin
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 22, Iss 2, Pp 112-123 (2022)
To ensure the safety and to secure the approval of injectable medicinal products based on antigen-specific immunoglobulins of animal origin, it is necessary to exclude their contamination with adventitious human pathogens. Ensuring the viral safety o
Externí odkaz:
https://doaj.org/article/f2096a613d76412da147fb6e6c3a7d3c
Publikováno v:
Антибиотики и Химиотерапия, Vol 59, Iss 7-8, Pp 30-36 (2020)
One hundred forty patients (the average age of 46.7±7.7 years) with hypertensive encephalopathy (HE) were observed. 74 patients of the main group received Cytoflavin® in a dose of 2 tablets twise a day in the standard basic therapy. 66 patients of
Externí odkaz:
https://doaj.org/article/d3b97152bb724fb797959e0a9646a89a
Publikováno v:
Анналы клинической и экспериментальной неврологии, Vol 9, Iss 4, Pp 24-29 (2017)
Eighty four patients with clinical signs of acute cerebrovasculardisease were examined. According to MRI, 20 patients were diagnosedwith venous infarction, and 64 patients were diagnosedwith arterial infarction. Venous strokes developed more frequent
Externí odkaz:
https://doaj.org/article/16e8dcb5dd76417da8ce149c23b2c5b0
Autor:
L. A. Belova, V. V. Mashin, L. V. Saprygina, M. A. Kravchenko, E. V. Gnedovskaya, E. V. Oshchepkova, Yu. Ya. Varakyn, Z. A. Suslina
Publikováno v:
Анналы клинической и экспериментальной неврологии, Vol 8, Iss 4, Pp 4-8 (2017)
We conducted an epidemiological study of an open population(aged 4059 yrs) restricted to the two therapeutic clusters of aregional out-patient clinic, Ulyanovsk city. A total of 500 peoplewere examined, including 157 men and 343 women. The meanage wa
Externí odkaz:
https://doaj.org/article/47b415b744a7457f95fac99c07971137
Autor:
V. V. Mashin, L. A. Belova, L. V. Saprygina, M. A. Kravchenko, Yu. Ya. Varakin, E. V. Gnedovskaya, Z. A. Suslina
Publikováno v:
Анналы клинической и экспериментальной неврологии, Vol 8, Iss 1, Pp 4-9 (2017)
The planning and assessment of therapeutic and preventivemeasures aimed at decreasing the burden of cardiovascular diseases(CVD) are impossible without reliable information concerningbasic epidemiologic characteristics and risk factors(RF) for these
Externí odkaz:
https://doaj.org/article/a97cbeff98624b4dae44f02a1081078c
Publikováno v:
Анналы клинической и экспериментальной неврологии, Vol 5, Iss 2, Pp 4-8 (2017)
To study abnormalities of central and cerebral hemodynamics inchronic cerebrovascular pathology, 65 patients were examinedwith long-term stable idiopathic arterial hypotension (IAH),mean age of 40.2 (8.1) years. According to neurologic examination,al
Externí odkaz:
https://doaj.org/article/403d149abd5142369ca3e7dceff13fa0
Publikováno v:
Анналы клинической и экспериментальной неврологии, Vol 1, Iss 4, Pp 43-47 (2017)
Externí odkaz:
https://doaj.org/article/c3b608711e7d421ca4f8c117380eadc7
Publikováno v:
Терапевтический архив, Vol 88, Iss 5, Pp 55-61 (2016)
Aim. To evaluate the impact of incorporating cytoflavin in a treatment regimen for patients with different stages of hypertensive disease (HD). Subjects and methods. The results of treatment were analyzed in 140 patients with HD (53 with Stage I, 50
Externí odkaz:
https://doaj.org/article/8f3169eec4ba46398336ed9ed89d3d99
Publikováno v:
Терапевтический архив, Vol 86, Iss 9, Pp 65-70 (2014)
AIM. To evaluate the efficacy of cytoflavin in the treatment of patients with hypertensive encephalopathy (HE). MATERIALS AND METHODS. One hundred and forty patients aged 39 to 73 years, diagnosed with HE, were examined and randomized to 2 groups. A
Externí odkaz:
https://doaj.org/article/730521c7b6904373989e3a0f42a1bfde
Autor:
V. V. Mashin, E. M. Dudikov, K. A. Zakuraeva, V. A. Lankov, O. I. Martynovich, A. V. Salomadina, L. A. Shalunova
Publikováno v:
Neurology Bulletin. :98-98